Orchestra BioMed Welcomes Christopher Cleary to Board of Directors
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the appointment of Christopher Cleary as an independent member of its Board of Directors, effective January 30, 2025. A …
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors Read More